tetanus-cmv fusion peptide vaccine

Vaccineexperimental

Clinical trial activity

2 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Dec 1, 2006 (NCT00722839)

Timeline

2000s

  1. Jan 1, 2006

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • padre-cmv fusion peptide vaccine
  • tetanus-cmv fusion peptide vaccine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01588015Phase 1Aug 1, 2012City of Hope National Medical Center, National Cancer Institute (NCI)
NCT00722839Phase 1Dec 1, 2006City of Hope National Medical Center, National Cancer Institute (NCI)
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
City of Hope National Medical CenterAcademic/Hospital2212006
National Cancer Institute (NCI)Government2012006
2 organizations
Page 1 / 1